This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2) | MicrobiomeTrials
← Back to trials NCT05302375
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2) Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-07-01Est. Completion: 2026-07-31
Enrollment target: 30 participantsLocations Dartmouth Cancer Center St. Johnsbury, Saint Johnsbury, Vermont, United States Other microbiome trials you might be interested in Ovarian Cancer Recurrent Ovarian Cancer Platinum Resistant Ovarian Cancer
The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and als…
Detroit, United States Completed Sep 30, 2026
Lung Neoplasms Neoadjuvant Therapy Immunotherapy Minimal Residual Disease
This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…
Beijing, China Est. completion Oct 31, 2027
Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
This randomized phase II trial studies how well tamoxifen citrate works compared with z-endoxifen hydrochloride in treat…
Mobile, United States Est. completion Nov 6, 2020